Abstract:The production of anti-tumor human monoclonal antibodies (MAbs) by human-human or human-mouse hybridoma technology was studied. UC729-6, a human lymphoblastoid cell line, or NS-1, a mouse myeloma cell line, were fused with lymphocytes isolated from regional lymph modes of 26 patients with breast or gastrointestinal cancer, resulting in 130 immunoglobulin-secreting human-human hybrids and 21 human-mouse hybrids. The supernatants of 88 hybrids were screened against a panel of cancer cells. The supernatants of 37 human-human hybrids and 2 human-mouse hybrids reacted with cancer cell lines. After three times subcloning, only one anti-breast cancer hybrid human MAb, IgG(lambda) human-human hybridoma (MUBL-6), and one anti-gastric cancer human MAb, IgM(lambda) human-mouse hybridoma (HMG-1), were obtained. The antibody-secreting level was 1-4 micrograms/ml/24 h. Production of anti-breast cancer human MAbs by Epstein-Barr virus (EBV) hybridoma was also studied. Human lymphocytes were derived from draining lymph nodes of a breast cancer patient, whose serum antibody strongly reacted with tumor associated antigen (TAA). The enriched B cells were transformed with EBV in vitro. Positive antibody-secreting B cells were selected, expanded, and fused with heteromyeloma SHMD-33. The fusion frequency was 28/10(7) lymphocytes. Among them were 16 hybridomas secreting human immunoglobulin. After subcloning, 60% of the cloned hybridomas kept their antibody-secreting ability. Six observed hybridomas remained stable for more than 1 year in tissue cultures. The antibody-secreting level was 2.9-30 micrograms/ml/24 h. Supernatants from these hybridomas all reacted with breast cancer cell lines but not with gastric cancer cell lines.(ABSTRACT TRUNCATED AT 250 WORDS)

[Preparation of Monoclonal Antibodies Against Multiple Antigens].

Microsoft Word-Yuan et al PDF

[Preparation of Monoclonal Antibodies Against Human Mesenchymal Stem Cells].

High throughput monoclonal antibody generation by immunizing multiple antigens

Production and Application of Monoclonal Antibodies to GST

[Preparation of Monoclonal Antibody Based on Single Intrasplenic Immunization of Plasmid DNA].

Preparation and Identification of Monoclonal Antibodies Against Luman-N-term Fusion

Preparation and Identification of Monoclonal Antibodies Against Zhangfei Fusion Protein

[Preparation and Identification of Monoclonal Antibody Against Alpha-Momorcharins].

Preparation and Application of Monoclonal Antibodies Against Allergen Glb-1

[Preparation and Identification of Monoclonal Antibodies Against Type M/N and Glycophorin A/B].

Preparation of Organophosphorus Pesticide Monoclonal Antibodies Against Multiple Antigens

Preparation,identification and preliminary application of monoclonal antibodies against recombinant human basic fibroblast growth factor

A Method for Preparation of Large Quantity of Murine Polyclonal Antibodies

Production of Anti-Tumor Human Monoclonal Antibodies Using Different Approaches.

Preparation and identification of monoclonal antibodies against Luman-recruiting factor N-terminal

Preparation and preliminary characterization of monoclonalantibodies against Pheromonicin-and-Staphylococcus aureus

[Preparation and Identification of Monoclonal Antibody Against Heterogeneous Nuclear Ribonucleoprotein B1].

Preparation and Characterization of Monoclonal Antibody Against Human Leukocytes

[Preparation, Epitope Analysis and Clinical Application of Monoclonal Antibodies Against Heart-Type Fatty Acid Binding Protein].

Preparation of a functional monoclonal antibody against human 4-1BBL molecule and analysis of its biological characteristics